Recently, SIRT1 has been demonstrated to promote Bcr-Abl-driven leukemogenesis and the survival of chronic myelogenous leukemia stem cells [18,19]. Here, SIRT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.